Resonant Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Buy
15,803
+542
+4% +$186K 0.27% 64
2026
Q1
$5.37M Buy
15,261
+416
+3% +$148K 0.28% 62
2025
Q4
$4.86M Buy
14,845
+1,352
+10% +$429K 0.27% 65
2025
Q3
$3.81M Buy
13,493
+329
+2% +$95.4K 0.22% 78
2025
Q2
$3.68M Buy
13,164
+313
+2% +$88.7K 0.23% 80
2025
Q1
$4M Buy
12,851
+858
+7% +$253K 0.28% 74
2024
Q4
$3.13M Sell
11,993
-229
-2% -$67.9K 0.23% 84
2024
Q3
$3.94M Buy
12,222
+89
+0.7% +$29.1K 0.29% 70
2024
Q2
$3.79M Buy
12,133
+487
+4% +$143K 0.31% 70
2024
Q1
$3.31M Buy
11,646
+73
+0.6% +$21.4K 0.28% 76
2023
Q4
$3.33M Sell
11,573
-1,073
-8% -$292K 0.32% 66
2023
Q3
$3.4M Buy
12,646
+281
+2% +$70.1K 0.36% 62
2023
Q2
$2.75M Sell
12,365
-324
-3% -$75.2K 0.3% 79
2023
Q1
$3.07M Buy
12,689
+197
+2% +$48.4K 0.35% 72
2022
Q4
$3.28M Buy
12,492
+99
+0.8% +$26.5K 0.41% 62
2022
Q3
$2.79M Buy
12,393
+77
+0.6% +$18.7K 0.42% 66
2022
Q2
$3M Buy
12,316
+187
+2% +$45.8K 0.47% 60
2022
Q1
$2.95M Buy
12,129
+854
+8% +$196K 0.44% 61
2021
Q4
$2.54M Buy
11,275
+1,823
+19% +$385K 0.38% 61
2021
Q3
$2.01M Buy
9,452
+1,449
+18% +$334K 0.35% 67
2021
Q2
$1.95M Buy
8,003
+219
+3% +$53.9K 0.38% 62
2021
Q1
$1.94M Buy
7,784
+824
+12% +$197K 0.4% 57
2020
Q4
$1.6M Buy
6,960
+647
+10% +$149K 0.38% 58
2020
Q3
$1.6M Sell
6,313
-117
-2% -$29K 0.46% 44
2020
Q2
$1.52M Sell
6,430
-2,283
-26% -$521K 0.44% 47
2020
Q1
$1.77M Buy
8,713
+1,060
+14% +$232K 0.64% 43
2019
Q4
$1.84M Buy
+7,653
New +$1.69M 0.58% 55

Other funds holding AMGN

Resonant Capital Advisors's AMGN Position: Q2 2026 in Review

Resonant Capital Advisors increased its Amgen (AMGN) stake by 3.6% in Q2 2026, buying an estimated $186K and bringing the position to 15,803 shares worth $5.72M. The position accounts for 0.27% of the portfolio, ranked #64.

Resonant Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Resonant Capital Advisors held 15,803 shares of Amgen worth $5.72M as of Q2 2026.
  • Resonant Capital Advisors bought 542 Amgen shares in Q2 2026, an estimated $186K.
  • Amgen made up 0.27% of Resonant Capital Advisors's portfolio in Q2 2026, its #64 holding.
  • Resonant Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.